AG008TKE

1021950-26-4 | Cabozantinib

Chemical structure of Cabozantinib, CAS 1021950-26-4
AG008TKE
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 1021950-26-4
Catalog Number AG008TKE(AGN-PC-04UMIG)
Chemical Name Cabozantinib
IUPAC Name 1-N'-(4-fluorophenyl)-1-N-[4-[[2-(2-morpholin-4-ylethylcarbamoyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]oxy]phenyl]cyclopropane-1,1-dicarboxamide
InChI InChI=1S/C31H31FN6O5/c32-20-1-3-21(4-2-20)35-29(40)31(10-11-31)30(41)36-22-5-7-23(8-6-22)43-26-9-12-33-27-24(26)19-25(37-27)28(39)34-13-14-38-15-17-42-18-16-38/h1-9,12,19H,10-11,13-18H2,(H,33,37)(H,34,39)(H,35,40)(H,36,41)
InChI Key PKOVTRMHYNEBDU-UHFFFAOYSA-N
MDL Number MFCD17010276
Molecular Formula C31H31FN6O5
Molecular Weight 586.6134
SMILES O=C(NC1C=CC(F)=CC=1)C1(CC1)C(=O)NC1C=CC(OC2C=CN=C3NC(=CC=23)C(=O)NCCN2CCOCC2)=CC=1
Synonyms
Tyrosine kinase inhibitor, 1021950-26-4, SCHEMBL10108314, C31H31FN6O5, DTXSID40648066, BCP04781, EX-A2282, MDK-0264, 4136AH, ZINC43195804, AKOS030526205, CS-0524, NCGC00390567-01, 4CA-1357, HY-10421, FT-0753909, EC-000.2366, W-5668, 1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N-[4-[[2-[[[2-(4-morpholinyl)ethyl]amino]carbonyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]oxy]phenyl]-, N'1-(4-fluorophenyl)-N1-{4-[(2-{[2-(morpholin-4-yl)ethyl]carbamoyl}-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl}cyclopropane-1,1-dicarboxamide, N~1~-(4-Fluorophenyl)-N'~1~-{4-[(2-{[2-(morpholin-4-yl)ethyl]carbamoyl}-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl}cyclopropane-1,1-dicarboxamide, 1,1-Cyclopropanedicarboxamide, XL184, XL-184, A15267, 1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[2-[[[2-(4-morpholinyl)ethyl]amino]carbonyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]oxy]phenyl]-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited